We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
KAVIGALE, sipavibart, 300 mg in 2 mL (150 mg/mL), Solution for injection/infusion vial. (2024-25)
Product name
KAVIGALE, sipavibart, 300 mg in 2 mL (150 mg/mL), Solution for injection/infusion vial.
Sponsor name
AstraZeneca Pty Ltd
Year Range
2024-25